Viewing Study NCT00323518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-01-27 @ 3:12 AM
Study NCT ID: NCT00323518
Status: COMPLETED
Last Update Posted: 2016-04-13
First Post: 2006-05-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
Sponsor: CuraGen Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Oral Mucositis View
None Stomatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None oral mucositis View
None hematologic View
None autologous stem cell transplant View
None velafermin View
None stomatitis View
None oncology - supportive care View
None mouth diseases View